期刊文献+

经引流管逆行注入氨甲环酸降低初次全髋置换术后失血量的有效性及近期安全性评估 被引量:12

原文传递
导出
摘要 目的探讨经引流管逆行注入氨甲环酸降低初次全髋置换术后失血量的有效性及近期安全性。方法选取2012年12月至2013年11月初次行单侧生物型全髋关节置换术的60例患者为研究对象。随机分为试验组和对照组。试验组将2 g氨甲环酸溶于50 ml 0.9%氯化钠溶液中,在关闭切口后经引流管注入,夹管6 h。对照组,将50 ml 0.9%氯化钠溶液在关闭切口后经引流管注入,夹管6 h。观察指标包括术后总出血量、引流量、输血率及下肢深静脉血栓的发生率、肺栓塞的发生率。结果经引流管逆行注入2 g氨甲环酸可将全髋置换术后总出血量由1360 ml降低至847 ml,输血率由26%降至6.7%,并且未增加术后深静脉血栓或肺栓塞的发生率。结论经引流管逆行注入2 g氨甲环酸可显著降低初次生物型全髋置换术后出血量及输血率,近期安全性良好,远期安全性仍有待进一步研究。
出处 《中华关节外科杂志(电子版)》 CAS 2014年第5期84-87,共4页 Chinese Journal of Joint Surgery(Electronic Edition)
  • 相关文献

参考文献30

  • 1Lanting BA, MacDonald SJ. The painful total hip replacement: diagnosis and deliverance[ J]. Bone Joint J, 2013, 95 -B: 70 - 73.
  • 2Schrader P, Boy O, Schleiz W, et al. Determining the indication for primary total hip and knee replacement. Results of external quality assurance of over 270,000 primary total hip and knee replacements[ J]. Orthopade, 2008, 37 : 1016 - 1026.
  • 3裴福兴.中国髋、膝关节置换的现状及展望[J].中国骨与关节杂志,2012,1(1):4-8. 被引量:87
  • 4Gibon E, Courpied JP, Hamadouche M. Total joint replacement and blood loss: what is the best equation [ J]. Int Orthop, 2013, 37 : 735 - 739.
  • 5Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty[ J]. J Bone Joint Surg Am, 1999, 81 : 2 - 10.
  • 6Imai N, Dohmae Y, Suda K, et al. Tranexamic acid tbr reduction of blood loss during total hip arthroplasty [ J ]. J Arthroplasty, 2012, 27:1838-1843.
  • 7Gandhi R, Evans HM, Mahomed SR, et al. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis[ J]. BMC Res Notes, 2013, 6: 184.
  • 8Rajesparan K, Biant LC, Ahmad M, et al. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement[ J]. J Bone Joint Surg Br, 2009, 91 : 776 -783.
  • 9Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement[ J]. Br J Anaesth, 2003, 90 : 596 - 599.
  • 10Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults[J]. Surgery, 1962, 51 : 224 -232.

二级参考文献31

  • 1Lemaire R. Strategies for blood management in orthopaedic and trauma surgery[J]. J Bone Joint Surg Br, 2008, 90:1128 - 1136.
  • 2Kumar A. Perioperative management of anemia: limits of blood transfusion and alternatives to it [ J ]. Cleve Clin J Med, 2009, 76: 112-118.
  • 3Cardone D, Klein AA. Perioperative blood conservation[ J]. Eur J Anaesthesiol, 2009, 26:722 -729.
  • 4Erstad BL. Systemic hemostafie medications for reducing surgical blood loss[ J]. Ann Pharmacother, 2001, 35:925-934.
  • 5Kovesi T, Royston D. Pharmacological approaches to reducing allogeneic blood exposure[ J]. Vox Sang, 2003, 84:2 - 10.
  • 6Benoni G, Lethagen S, Nilsson P, et al. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty[J]. Acta Orthop Scand, 2000, 71 : 250 - 254.
  • 7Ekback G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery [ J ]. Anesth Analg, 2000, 91 : [ 1:24 - 1130.
  • 8Benoni G, Fredin H, Knebel R, et al. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double- blind study in 40 primary operations [ J ]. Acta Orthop Scand, 2001, 72 : 442 -448.
  • 9Husted H, Blond L, Sonne-Holm S, et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized doubleblind study in 40 patients[ J ]. Acta Orthop Scand, 2003, 74 : 665 - 669.
  • 10Lemay E, Guay J, Cote C, et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement[ J]. Can J Anaesth, 2004, 51 : 31 -37.

共引文献100

同被引文献145

引证文献12

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部